|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Ketosis Prone Diabetes | |||||
| Diabetic Ketoacidosis | |||||
| Severe Hyperglycemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 1 | |||||
| Hyperglycemia | |||||
| Ketosis | |||||
| 3 | More general conditions related to this trial | ||||
| Acid-Base Imbalance | |||||
| Acidosis | |||||
| Autoimmune Diseases | |||||
| Diabetes Complications | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| Emory University | |||||